Ischemic stroke, accounting for the majority of stroke events, significantly contributes to global morbidity and mortality. Vascular recanalization therapies, namely intravenous thrombolysis and mechanical thrombectomy, have emerged as critical interventions, yet their success hinges on timely application and patient-specific factors. This review focuses on the early phase pathophysiological mechanisms of ischemic stroke and the nuances of recanalization. It highlights the dual role of neutrophils in tissue damage and repair, and the critical involvement of the blood-brain barrier (BBB) in stroke outcomes. Special emphasis is placed on ischemia-reperfusion injury, characterized by oxidative stress, inflammation, and endothelial dysfunction, which paradoxically exacerbates cerebral damage post-revascularization. The review also explores the potential of targeting molecular pathways involved in BBB integrity and inflammation to enhance the efficacy of recanalization therapies. By synthesizing current research, this paper aims to provide insights into optimizing treatment protocols and developing adjuvant neuroprotective strategies, thereby advancing stroke therapy and improving patient outcomes. Visualizing the path to stroke recovery: This graphic abstract illuminates key insights into the early phase of ischemic stroke, emphasizing the groundbreaking recanalization therapies that are reshaping patient care. By illustrating the intricate dance of neutrophils, which play a dual role in tissue damage and repair, and shedding light on the critical importance of maintaining blood-brain barrier integrity, this depiction offers a clear view of the complex pathophysiology underlying stroke. Furthermore, it highlights the paradoxical effects of ischemia-reperfusion injury, suggesting novel molecular targets for enhancing recanalization therapy efficacy. Our review charts a course toward optimizing treatment strategies, underpinning the development of next-generation neuroprotective approaches in the quest to improve outcomes for stroke patients.image
基金:
Shenzhen Science and Technology
Program, Grant/Award Number:
JCYJ20220531092010023,
JCYJ20220531100203008 and
JCYJ20230807140721043; National
Natural Science Foundation of China,
Grant/Award Number: 82204983 and
82273923
第一作者机构:[1]First Hosp Jilin Univ, Stroke Ctr, Dept Neurol, Jilin, Peoples R China[2]Chinese Acad Sci, Inst Biomed & Biotechnol, Shenzhen Inst Adv Technol, Shenzhen, Guangdong, Peoples R China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
He Qianyan,Wang Yueqing,Fang Cheng,et al.Advancing stroke therapy: A deep dive into early phase of ischemic stroke and recanalization[J].CNS NEUROSCIENCE & THERAPEUTICS.2024,30(2):doi:10.1111/cns.14634.
APA:
He, Qianyan,Wang, Yueqing,Fang, Cheng,Feng, Ziying,Yin, Meifang...&Mo, Zhizhun.(2024).Advancing stroke therapy: A deep dive into early phase of ischemic stroke and recanalization.CNS NEUROSCIENCE & THERAPEUTICS,30,(2)
MLA:
He, Qianyan,et al."Advancing stroke therapy: A deep dive into early phase of ischemic stroke and recanalization".CNS NEUROSCIENCE & THERAPEUTICS 30..2(2024)